liver FBPase Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of liver FBPase monoclonal antibodies for investigating fructose-1,6-bisphosphatase in liver metabolism. liver FBPase Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fructose-1,6-bisphosphatase is a key regulatory enzyme in gluconeogenesis, playing a crucial role in glucose homeostasis and energy metabolism. The proper function of fructose-1,6-bisphosphatase is vital for maintaining blood sugar levels, especially during fasting states. Dysregulation of liver FBPase can lead to metabolic disorders, making it a significant target for research in diabetes and other metabolic diseases. Liver FBPase monoclonal antibodies enable researchers to explore metabolic regulation with precision and reliability. Understanding the mechanisms of fructose-1,6-bisphosphatase can provide insights into potential therapeutic strategies for metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies for liver FBPase support researchers worldwide in advancing our understanding of metabolic diseases and potential treatments.